Capcom announced that the cumulative sales of the "biochemical crisis" series of games exceeded 142 million copies.

CTOnews.com, June 7 (Xinhua)-- CAPCOM announced cumulative game sales figures for the "biochemical Evil", "Monster Hunter", "Street Fighter", "Locke Man" and "Ghost Cry" series at its latest earnings event.

Capcom said that in fiscal year 2022 (April 2022 to March 2023), global game sales totaled 47.1 million, which does not include games such as Street Fighter 6, which was launched this month.

According to Capcom's financial report data, CTOnews.com summarizes the information as follows:

The "biochemical Evil" series sold a total of 142 million copies. Capcom said that the "biochemical Evil" series sold a total of 15 million copies in fiscal year 2022, of which "biochemical Evil 4" sold 3 million in two days, "biochemical Evil 7" sold 2.2 million copies, and so on.

The Monster Hunter series sold a total of 9200 million copies, an increase of 8 million in fiscal year 2022, mainly due to 5.4 million sales of Monster Hunter: rise and 1.5 million sales of Monster Hunter World.

The cumulative sales of the "Street Fighter" series were 5000 million, an increase of 2 million in fiscal year 2022.

The "Locke Man" series sold a total of 3800 million copies and remained unchanged in fiscal year 2022.

The "Ghost cry" series sold a total of 2900 million copies, with an increase of 3 million copies driven by "Ghost crying 5".